Cancer 'moonshot' panel says immune therapies may be key
Ubicación actual:
> This Story

Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment




Rad Oncology Homepage

MD Anderson to expand proton therapy center with $159 million project Increases accessibility to higher number of patients

Radiotherapy beats anti-hormonal therapy for some breast cancer patients, says study Avoiding side effects such as hot flashes, weight gain and bone fracture

New technique may concentrate radiotherapy dose for minimal tissue damage Utilizes very high energy electrons (VHEEs)

MedAustron delivers first bout of carbon ion therapy on patient Sixth center in the world to offer treatment

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

Elekta to distribute C-RAD SIGRT technology in North America and Mexico Advances stereotactic radiosurgery and stereotactic body radiotherapy

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

FDA gives RaySearch green light for RayStation 8B platform First treatment planning system to offer machine learning applications

MedAustron to add health IT to proton and carbon ion treatment facilities Orders more than $13 million worth of RaySearch systems

'Nudge' in EHRs cuts imaging in half for palliative radiotherapy, says study Reduces duration of radiotherapy sessions

Vice President Joe Biden leads
the Moonshot initiative

Cancer 'moonshot' panel says immune therapies may be key

por Thomas Dworetzky , Contributing Reporter
The Cancer Moonshot Blue Ribbon Panel headed by Vice President Joe Biden has issued a draft report highlighting 10 key recommendations.

The moonshot effort was called an “enormous, once-in-a-lifetime opportunity for the cancer community and our nation to battle the disease,” by the panel's co-chairs Tyler Jacks, Ph.D., director of MIT's Koch Institute for Integrative Cancer Research, Dr. Elizabeth Jaffee, professor and deputy director for translational research at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, and Dinah Singer, Ph.D., acting deputy director, National Cancer Institute.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

"We are truly at an inflection point for preventing and treating cancer, which is the result of decades of dedicated efforts to increase our knowledge and understanding of the more than 200 diseases called cancer," Dr. Margaret Foti, chief executive officer of the American Association for Cancer Research, said in a separate statement about the panel report.

The report zeroes in on “a finite set of programs that are poised for acceleration, and that could unleash new cancer breakthroughs if implemented." A number of them highlight the growing importance of big data in medical research and practice.

The panel's recommendations include:

• Engage patients to contribute their comprehensive tumor profile data to expand knowledge about what therapies work, in whom, and in which types of cancer.
• Establish a cancer immunotherapy clinical trials network devoted exclusively to discovering and evaluating immunotherapy approaches.
• Identify therapeutic targets to overcome drug resistance through studies that determine the mechanisms that lead cancer cells to become resistant to previously effective treatments.
• Create a national ecosystem for sharing and analyzing cancer data so that researchers, clinicians, and patients will be able to contribute data, which will facilitate efficient data analysis.
• Improve understanding of fusion oncoproteins in pediatric cancer and use new preclinical models to develop inhibitors that target them.
• Accelerate the development of guidelines for routine monitoring and management of patient-reported symptoms to minimize debilitating side effects of cancer and its treatment.
• Reduce cancer risk and cancer health disparities through approaches in development, testing and broad adoption of proven prevention strategies.
  Pages: 1 - 2 >>

Rad Oncology Homepage

You Must Be Logged In To Post A Comment